Загрузка...
Parkinson's disease: an open label trial of pergolide in patients failing bromocriptine therapy.
Sixty-three patients with Parkinson's disease who failed bromocriptine therapy for various reasons were treated in an open-label trial of pergolide. The data were evaluated in a retrospective manner. Forty-six percent had a good response and tolerated the pergolide. A comparison of the outcomes...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
1988
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1032966/ https://ncbi.nlm.nih.gov/pubmed/3288717 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|